1004618-85-2 Usage
General Description
4-(4-(TrifluoroMethoxy)phenyl)piperidine hydrochloride is a chemical compound with the molecular formula C13H18F3NO. It is a piperidine derivative that contains a trifluoromethoxyphenyl group. 4-(4-(TrifluoroMethoxy)phenyl)piperidine hydrochloride is typically found in the form of a white crystalline powder and is commonly used in medicinal chemistry and pharmaceutical research. It has shown potential as a serotonin reuptake inhibitor and has been studied for its potential use in the treatment of various neurological and psychiatric disorders. Additionally, it has also been investigated for its analgesic and anti-inflammatory properties. 4-(4-(TrifluoroMethoxy)phenyl)piperidine hydrochloride is typically used in laboratory research and is not approved for clinical use in humans.
Check Digit Verification of cas no
The CAS Registry Mumber 1004618-85-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,6,1 and 8 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1004618-85:
(9*1)+(8*0)+(7*0)+(6*4)+(5*6)+(4*1)+(3*8)+(2*8)+(1*5)=112
112 % 10 = 2
So 1004618-85-2 is a valid CAS Registry Number.
1004618-85-2Relevant articles and documents
(6,7-DIHYDRO-2-NITRO-5H-IMIDAZOL[2,1-B][1,3]OXAZIN-6-YL) AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
-
Paragraph 0075-0076, (2013/04/10)
(6,7-Dihydro-2-nitro-5H-imidazo [2,1-b][1,3]oxazin-6-yl)amide compounds of formula (I), and their pharmaceutically acceptable salts, preparation methods and pharmaceutical compositions thereof are disclosed, wherein m and R are defined as in the descripti
BENZIMIDAZOLYL COMPOUNDS AS POTENTIATORS OF MGLUR2 SUBTYPE OF GLUTAMATE RECEPTOR
-
Page/Page column 65-66, (2010/11/30)
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
